EMEA (Europe, Middle East and Africa) Insomnia Pharmacological Treatment Market Report 2018

January 2018 | 105 pages | ID: E006A32BDF0EN
QYResearch

Abstracts

In this report, the EMEA Insomnia Pharmacological Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Insomnia Pharmacological Treatment for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Insomnia Pharmacological Treatment market competition by top manufacturers/players, with Insomnia Pharmacological Treatment sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eisai, Co. Ltd. (Japan)
• Merck & Co., Inc. (U.S.)
• Meda Consumer Healthcare Inc. (U.S.)
• Pfizer, Inc. (U.S.)
• Sanofi (France)
• Takeda Pharmaceutical Company Ltd. (Japan)
• Pernix Therapeutics (U.S.)
• Purdue Pharma L.P. (U.S.)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Prescription Sleep Aids
• Over-the-Counter Sleep Aids

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Homecare
• Clinic
• Hospital

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Insomnia Pharmacological Treatment Market Report 2018

1 INSOMNIA PHARMACOLOGICAL TREATMENT OVERVIEW

1.1 Product Overview and Scope of Insomnia Pharmacological Treatment
1.2 Classification of Insomnia Pharmacological Treatment
  1.2.1 EMEA Insomnia Pharmacological Treatment Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Insomnia Pharmacological Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Prescription Sleep Aids
  1.2.4 Over-the-Counter Sleep Aids
1.3 EMEA Insomnia Pharmacological Treatment Market by Application/End Users
  1.3.1 EMEA Insomnia Pharmacological Treatment Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Homecare
  1.3.3 Clinic
  1.3.4 Hospital
1.4 EMEA Insomnia Pharmacological Treatment Market by Region
  1.4.1 EMEA Insomnia Pharmacological Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Insomnia Pharmacological Treatment (2013-2025)
  1.5.1 EMEA Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Insomnia Pharmacological Treatment Revenue and Growth Rate (2013-2025)

2 EMEA INSOMNIA PHARMACOLOGICAL TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Insomnia Pharmacological Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Insomnia Pharmacological Treatment Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Insomnia Pharmacological Treatment Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Insomnia Pharmacological Treatment Sale Price by Players (2013-2018)
2.2 EMEA Insomnia Pharmacological Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Insomnia Pharmacological Treatment Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Insomnia Pharmacological Treatment Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Insomnia Pharmacological Treatment Sale Price by Type (2013-2018)
2.3 EMEA Insomnia Pharmacological Treatment (Volume) by Application
2.4 EMEA Insomnia Pharmacological Treatment (Volume and Value) by Region
  2.4.1 EMEA Insomnia Pharmacological Treatment Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Insomnia Pharmacological Treatment Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Insomnia Pharmacological Treatment Sales Price by Region (2013-2018)

3 EUROPE INSOMNIA PHARMACOLOGICAL TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Insomnia Pharmacological Treatment Sales and Value (2013-2018)
  3.1.1 Europe Insomnia Pharmacological Treatment Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Insomnia Pharmacological Treatment Revenue and Growth Rate (2013-2018)
3.2 Europe Insomnia Pharmacological Treatment Sales and Market Share by Type
3.3 Europe Insomnia Pharmacological Treatment Sales and Market Share by Application
3.4 Europe Insomnia Pharmacological Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Insomnia Pharmacological Treatment Sales Volume by Countries (2013-2018)
  3.4.2 Europe Insomnia Pharmacological Treatment Revenue by Countries (2013-2018)
  3.4.3 Germany Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  3.4.4 France Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  3.4.5 UK Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  3.4.6 Russia Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  3.4.7 Italy Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)

4 MIDDLE EAST INSOMNIA PHARMACOLOGICAL TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Insomnia Pharmacological Treatment Sales and Value (2013-2018)
  4.1.1 Middle East Insomnia Pharmacological Treatment Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Insomnia Pharmacological Treatment Revenue and Growth Rate (2013-2018)
4.2 Middle East Insomnia Pharmacological Treatment Sales and Market Share by Type
4.3 Middle East Insomnia Pharmacological Treatment Sales and Market Share by Application
4.4 Middle East Insomnia Pharmacological Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Insomnia Pharmacological Treatment Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Insomnia Pharmacological Treatment Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  4.4.4 Israel Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  4.4.5 UAE Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  4.4.6 Iran Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)

5 AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Insomnia Pharmacological Treatment Sales and Value (2013-2018)
  5.1.1 Africa Insomnia Pharmacological Treatment Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Insomnia Pharmacological Treatment Revenue and Growth Rate (2013-2018)
5.2 Africa Insomnia Pharmacological Treatment Sales and Market Share by Type
5.3 Africa Insomnia Pharmacological Treatment Sales and Market Share by Application
5.4 Africa Insomnia Pharmacological Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Insomnia Pharmacological Treatment Sales Volume by Countries (2013-2018)
  5.4.2 Africa Insomnia Pharmacological Treatment Revenue by Countries (2013-2018)
  5.4.3 South Africa Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Insomnia Pharmacological Treatment Sales and Growth Rate (2013-2018)

6 EMEA INSOMNIA PHARMACOLOGICAL TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Eisai, Co. Ltd. (Japan)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Insomnia Pharmacological Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Merck & Co., Inc. (U.S.)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Insomnia Pharmacological Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Meda Consumer Healthcare Inc. (U.S.)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Insomnia Pharmacological Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Pfizer, Inc. (U.S.)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Insomnia Pharmacological Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Sanofi (France)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Insomnia Pharmacological Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi (France) Insomnia Pharmacological Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Takeda Pharmaceutical Company Ltd. (Japan)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Insomnia Pharmacological Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Pernix Therapeutics (U.S.)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Insomnia Pharmacological Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Purdue Pharma L.P. (U.S.)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Insomnia Pharmacological Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 INSOMNIA PHARMACOLOGICAL TREATMENT MANUFACTURING COST ANALYSIS

7.1 Insomnia Pharmacological Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insomnia Pharmacological Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Insomnia Pharmacological Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insomnia Pharmacological Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET FORECAST (2018-2025)

11.1 EMEA Insomnia Pharmacological Treatment Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Insomnia Pharmacological Treatment Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Insomnia Pharmacological Treatment Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Insomnia Pharmacological Treatment Price and Trend Forecast (2018-2025)
11.2 EMEA Insomnia Pharmacological Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Insomnia Pharmacological Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Insomnia Pharmacological Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Insomnia Pharmacological Treatment Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Insomnia Pharmacological Treatment Sales Forecast by Type (2018-2025)
11.7 EMEA Insomnia Pharmacological Treatment Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Insomnia Pharmacological Treatment
Figure EMEA Insomnia Pharmacological Treatment Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Insomnia Pharmacological Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure Prescription Sleep Aids Product Picture
Figure Over-the-Counter Sleep Aids Product Picture
Figure EMEA Insomnia Pharmacological Treatment Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Insomnia Pharmacological Treatment by Application in 2017
Figure Homecare Examples
Table Key Downstream Customer in Homecare
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure EMEA Insomnia Pharmacological Treatment Market Size (Million USD) by Region (2013-2025)
Figure Europe Insomnia Pharmacological Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Insomnia Pharmacological Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Insomnia Pharmacological Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Insomnia Pharmacological Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Insomnia Pharmacological Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Insomnia Pharmacological Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Insomnia Pharmacological Treatment Sales Volume and Growth Rate (2013-2025)
Figure EMEA Insomnia Pharmacological Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Insomnia Pharmacological Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Sales Share by Players (2013-2018)
Figure 2017 Insomnia Pharmacological Treatment Sales Share by Players
Figure 2017 Insomnia Pharmacological Treatment Sales Share by Players
Figure EMEA Insomnia Pharmacological Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Revenue (Million USD) by Players (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Revenue Share by Players (2013-2018)
Table 2017 EMEA Insomnia Pharmacological Treatment Revenue Share by Players
Table 2017 EMEA Insomnia Pharmacological Treatment Revenue Share by Players
Table EMEA Insomnia Pharmacological Treatment Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Sales Share by Type (2013-2018)
Figure Sales Market Share of Insomnia Pharmacological Treatment by Type (2013-2018)
Figure EMEA Insomnia Pharmacological Treatment Sales Market Share by Type (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Insomnia Pharmacological Treatment by Type in 2017
Table EMEA Insomnia Pharmacological Treatment Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Sales Share by Application (2013-2018)
Figure Sales Market Share of Insomnia Pharmacological Treatment by Application (2013-2018)
Figure EMEA Insomnia Pharmacological Treatment Sales Market Share by Application in 2017
Table EMEA Insomnia Pharmacological Treatment Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Sales Share by Region (2013-2018)
Figure Sales Market Share of Insomnia Pharmacological Treatment by Region (2013-2018)
Figure EMEA Insomnia Pharmacological Treatment Sales Market Share in 2017
Table EMEA Insomnia Pharmacological Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Insomnia Pharmacological Treatment Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Insomnia Pharmacological Treatment by Region (2013-2018)
Figure EMEA Insomnia Pharmacological Treatment Revenue Market Share Regions in 2017
Table EMEA Insomnia Pharmacological Treatment Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Insomnia Pharmacological Treatment Revenue and Growth Rate (2013-2018)
Table Europe Insomnia Pharmacological Treatment Sales (K Pcs) by Type (2013-2018)
Table Europe Insomnia Pharmacological Treatment Market Share by Type (2013-2018)
Figure Europe Insomnia Pharmacological Treatment Market Share by Type in 2017
Table Europe Insomnia Pharmacological Treatment Sales (K Pcs) by Application (2013-2018)
Table Europe Insomnia Pharmacological Treatment Market Share by Application (2013-2018)
Figure Europe Insomnia Pharmacological Treatment Market Share by Application in 2017
Table Europe Insomnia Pharmacological Treatment Sales (K Pcs) by Countries (2013-2018)
Table Europe Insomnia Pharmacological Treatment Sales Market Share by Countries (2013-2018)
Figure Europe Insomnia Pharmacological Treatment Sales Market Share by Countries (2013-2018)
Figure Europe Insomnia Pharmacological Treatment Sales Market Share by Countries in 2017
Table Europe Insomnia Pharmacological Treatment Revenue (Million USD) by Countries (2013-2018)
Table Europe Insomnia Pharmacological Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Insomnia Pharmacological Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Insomnia Pharmacological Treatment Revenue Market Share by Countries in 2017
Figure Germany Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Insomnia Pharmacological Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Insomnia Pharmacological Treatment Sales (K Pcs) by Type (2013-2018)
Table Middle East Insomnia Pharmacological Treatment Market Share by Type (2013-2018)
Figure Middle East Insomnia Pharmacological Treatment Market Share by Type (2013-2018)
Table Middle East Insomnia Pharmacological Treatment Sales (K Pcs) by Applications (2013-2018)
Table Middle East Insomnia Pharmacological Treatment Market Share by Applications (2013-2018)
Figure Middle East Insomnia Pharmacological Treatment Sales Market Share by Application in 2017
Table Middle East Insomnia Pharmacological Treatment Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Insomnia Pharmacological Treatment Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Insomnia Pharmacological Treatment Sales Volume Market Share by Countries in 2017
Table Middle East Insomnia Pharmacological Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East Insomnia Pharmacological Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East Insomnia Pharmacological Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East Insomnia Pharmacological Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Insomnia Pharmacological Treatment Sales (K Pcs) by Type (2013-2018)
Table Africa Insomnia Pharmacological Treatment Sales Market Share by Type (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Sales Market Share by Type (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Sales Market Share by Type in 2017
Table Africa Insomnia Pharmacological Treatment Sales (K Pcs) by Application (2013-2018)
Table Africa Insomnia Pharmacological Treatment Sales Market Share by Application (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Sales Market Share by Application (2013-2018)
Table Africa Insomnia Pharmacological Treatment Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Insomnia Pharmacological Treatment Sales Market Share by Countries (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Sales Market Share by Countries (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Sales Market Share by Countries in 2017
Table Africa Insomnia Pharmacological Treatment Revenue (Million USD) by Countries (2013-2018)
Table Africa Insomnia Pharmacological Treatment Revenue Market Share by Countries (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Revenue Market Share by Countries (2013-2018)
Figure Africa Insomnia Pharmacological Treatment Revenue Market Share by Countries in 2017
Figure South Africa Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Table Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Basic Information List
Table Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Sales Market Share in EMEA (2013-2018)
Figure Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue Market Share in EMEA (2013-2018)
Table Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Basic Information List
Table Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Sales Market Share in EMEA (2013-2018)
Figure Merck & Co., Inc. (U.S.) Insomnia Pharmacological Treatment Revenue Market Share in EMEA (2013-2018)
Table Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Basic Information List
Table Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Sales Market Share in EMEA (2013-2018)
Figure Meda Consumer Healthcare Inc. (U.S.) Insomnia Pharmacological Treatment Revenue Market Share in EMEA (2013-2018)
Table Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Basic Information List
Table Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Sales Market Share in EMEA (2013-2018)
Figure Pfizer, Inc. (U.S.) Insomnia Pharmacological Treatment Revenue Market Share in EMEA (2013-2018)
Table Sanofi (France) Insomnia Pharmacological Treatment Basic Information List
Table Sanofi (France) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi (France) Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Sanofi (France) Insomnia Pharmacological Treatment Sales Market Share in EMEA (2013-2018)
Figure Sanofi (France) Insomnia Pharmacological Treatment Revenue Market Share in EMEA (2013-2018)
Table Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Basic Information List
Table Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Sales Market Share in EMEA (2013-2018)
Figure Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue Market Share in EMEA (2013-2018)
Table Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Basic Information List
Table Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Sales Market Share in EMEA (2013-2018)
Figure Pernix Therapeutics (U.S.) Insomnia Pharmacological Treatment Revenue Market Share in EMEA (2013-2018)
Table Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Basic Information List
Table Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Sales Market Share in EMEA (2013-2018)
Figure Purdue Pharma L.P. (U.S.) Insomnia Pharmacological Treatment Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insomnia Pharmacological Treatment
Figure Manufacturing Process Analysis of Insomnia Pharmacological Treatment
Figure Insomnia Pharmacological Treatment Industrial Chain Analysis
Table Raw Materials Sources of Insomnia Pharmacological Treatment Major Manufacturers in 2017
Table Major Buyers of Insomnia Pharmacological Treatment
Table Distributors/Traders List
Figure EMEA Insomnia Pharmacological Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Insomnia Pharmacological Treatment Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Insomnia Pharmacological Treatment Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Insomnia Pharmacological Treatment Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Insomnia Pharmacological Treatment Sales Market Share Forecast by Region (2018-2025)
Table EMEA Insomnia Pharmacological Treatment Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Insomnia Pharmacological Treatment Revenue Market Share Forecast by Region (2018-2025)
Table Europe Insomnia Pharmacological Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Insomnia Pharmacological Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Europe Insomnia Pharmacological Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Insomnia Pharmacological Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Insomnia Pharmacological Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Insomnia Pharmacological Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Insomnia Pharmacological Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Insomnia Pharmacological Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Insomnia Pharmacological Treatment Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Insomnia Pharmacological Treatment Sales Market Share Forecast by Countries (2018-2025)
Table Africa Insomnia Pharmacological Treatment Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Insomnia Pharmacological Treatment Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Insomnia Pharmacological Treatment Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Insomnia Pharmacological Treatment Sales Market Share Forecast by Type (2018-2025)
Table EMEA Insomnia Pharmacological Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Insomnia Pharmacological Treatment Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources